NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand cash
Cash and short-term investments held at the end of each period.
NutriBand's cash was $3.42M at Jul 31, 2026. For fiscal 2026 it was $4.57M, up 6.1% from the year before. The highest annual figure on record is $4.89M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $4.57M | +6.1% |
| FY2025 | Jan 31, 2025 | $4.31M | +774.7% |
| FY2024 | Jan 31, 2024 | $492.94K | -75.2% |
| FY2023 | Jan 31, 2023 | $1.99M | -59.4% |
| FY2022 | Jan 31, 2022 | $4.89M | +3118.5% |
| FY2021 | Jan 31, 2021 | $151.99K | +1392.9% |
| FY2020 | Jan 31, 2020 | $10.18K | -97.9% |
| FY2019 | Jan 31, 2019 | $474.65K | +1649.9% |
| FY2017 | Jan 31, 2017 | $27.12K | +27024.0% |
| FY2016 | Jan 31, 2016 | $100 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $3.42M | -51.1% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $4.01M | +35.2% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $4.57M | +6.1% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $5.31M | -6.8% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $7.00M | +3.5% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $2.96M | -64.5% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $4.31M | +774.7% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $5.70M | +350.3% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $6.76M | +189.6% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $8.35M | +553.1% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $492.94K | -75.2% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $1.27M | -55.1% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $2.33M | -30.2% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $1.28M | -68.1% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $1.99M | -59.4% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $2.82M | -48.7% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $3.34M | +714.2% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $4.01M | +2538.7% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $4.89M | +2429.5% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $5.49M | +13876.1% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $410.75K | +1889.7% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $151.99K | +1392.9% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $193.39K | +98.4% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $39.25K | +183.7% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $20.64K | -89.8% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $10.18K | -97.9% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $97.47K | -62.2% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $13.83K | -98.7% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $201.85K | +197790.2% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $474.65K | +5988.4% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $257.55K | +43330.9% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $1.10M | +3945.1% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $102 | -98.4% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $7.80K | +25.2% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $593 | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $27.12K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | $6.23K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | $6.23K | – |
See a number that looks wrong?